Dicerna CEO’s pay doubles for second year in a row

Dicerna’s board boosted the CEO’s stock in the company to place him in line with other biopharma chief executives, according to a company spokesperson.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.